About Caplin Point laboratories
Caplin Point laboratories is a company based in Chennai (India) founded in 1990. The company has 5,530 employees as of March 31, 2024. Caplin Point laboratories offers products and services including Injectables and Generics.
- Headquarter Chennai, India
- Employees 5530 as on 31 Mar, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Caplin Point Laboratories Limited
-
Annual Revenue
$224.42 M (USD)14.58as on Mar 31, 2024
-
Net Profit
$62.62 M (USD)17.33as on Mar 31, 2024
-
EBITDA
$74.88 M (USD)18.53as on Mar 31, 2024
-
Latest Funding Round
$30.6 M (USD), Post-IPO
Jan 21, 2019
-
Investors
Eight Roads Ventures
& 1 more
-
Employee Count
5530
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Caplin Point laboratories
Caplin Point laboratories is a publicly listed company on the NSE with ticker symbol CAPLIPOINT in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Caplin Point laboratories
Caplin Point laboratories offers a comprehensive portfolio of products and services, including Injectables and Generics.
Injectables are manufactured for various markets, including regulated ones, and are exported globally.
Generics and branded generics are produced and distributed, covering therapies like psychiatric and oncology.
People of Caplin Point laboratories
Unlock access to complete
Unlock access to complete
Funding Insights of Caplin Point laboratories
Investors in Caplin Point laboratories
Caplin Point laboratories has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Eight Roads Ventures and F-Prime Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment and global platform support for startups.
|
Locked | Locked | Locked | |
|
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
|
Locked | Locked | Locked |
Investor details for Caplin Point laboratories
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Caplin Point laboratories
Investment portfolio details for Caplin Point laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Caplin Point laboratories
Detailed financials for Caplin Point laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Caplin Point Laboratories Comparisons
Peer comparison for Caplin Point laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Caplin Point laboratories
Detailed competitors of Caplin Point laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Caplin Point Laboratories
Complete news archive for Caplin Point laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Caplin Point laboratories
Caplin Point laboratories was founded in 1990 and raised its 1st funding round 29 years after it was founded.
Caplin Point laboratories is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Sridhar Ganesan is the current CEO of Caplin Point laboratories.
As of Mar 31, 2024, the latest employee count at Caplin Point laboratories is 5,530.
Annual revenue of Caplin Point laboratories is $224.42M as on Mar 31, 2024.
Caplin Point Laboratories was founded in 1990 and is headquartered in Chennai, India. Operations focus on the pharmaceutical and biotech sectors, where a variety of generics and biotech products are produced. Contract manufacturing services are also provided. The companys presence extends to Europe, Africa, and America, supporting international distribution. Leadership is provided by CEO Sridhar Ganesan.
Caplin Point laboratories offers Injectables and Generics.
Yes, Caplin Point laboratories is publicly traded on NSE under the ticker symbol CAPLIPOINT.
Caplin Point laboratories has 2 investors. Key investors include Eight Roads Ventures, and F-Prime Capital.
The ticker symbol of Caplin Point laboratories is CAPLIPOINT on NSE.